
2018: Company founded; completed laboratory validation of its first bioactive ingredient extraction technology.
2020: Launched its first IoT-based smart health bracelet, enabling real-time health data monitoring and cloud synchronization, marking the beginning of the “Biotechnology + IoT” integrated business model.
2022: Recognized as a National High-Tech Enterprise; patent portfolio exceeded 10 items; branch network expanded to cover 20 provinces across China.
2023: Established research collaboration with leading Grade A tertiary hospitals in China to conduct clinical application studies of biological preparations, advancing products toward medical-grade standards.
2024: Achieved a major breakthrough in overseas business; products obtained EU CE certification and officially entered the European market, marking a key milestone in international expansion.
2025: Completed the construction of an intelligent pilot-scale workshop, significantly enhancing production capacity and quality control; total patents reached 23, further strengthening R&D capabilities.